CN106754837B - Proline protease mutant and application thereof - Google Patents
Proline protease mutant and application thereof Download PDFInfo
- Publication number
- CN106754837B CN106754837B CN201611130005.1A CN201611130005A CN106754837B CN 106754837 B CN106754837 B CN 106754837B CN 201611130005 A CN201611130005 A CN 201611130005A CN 106754837 B CN106754837 B CN 106754837B
- Authority
- CN
- China
- Prior art keywords
- ala
- gly
- val
- ser
- thr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 title claims abstract description 29
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 title claims abstract description 21
- 108091005804 Peptidases Proteins 0.000 title claims abstract description 19
- 239000004365 Protease Substances 0.000 title claims abstract description 19
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title claims abstract description 18
- 235000013405 beer Nutrition 0.000 claims abstract description 34
- 108090000623 proteins and genes Proteins 0.000 claims description 29
- 108010017314 prolyl dipeptidase Proteins 0.000 claims description 26
- 150000001413 amino acids Chemical class 0.000 claims description 14
- 239000013612 plasmid Substances 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 35
- 102000004190 Enzymes Human genes 0.000 abstract description 34
- 108090000790 Enzymes Proteins 0.000 abstract description 34
- 238000006243 chemical reaction Methods 0.000 abstract description 16
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 238000012216 screening Methods 0.000 abstract description 6
- 238000010353 genetic engineering Methods 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- 229940088598 enzyme Drugs 0.000 description 33
- 241000228245 Aspergillus niger Species 0.000 description 19
- 238000000855 fermentation Methods 0.000 description 18
- 230000004151 fermentation Effects 0.000 description 18
- 102000004169 proteins and genes Human genes 0.000 description 17
- 235000018102 proteins Nutrition 0.000 description 16
- 239000000243 solution Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 9
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 9
- 230000009467 reduction Effects 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 8
- 239000007853 buffer solution Substances 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 108010026333 seryl-proline Proteins 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 5
- 230000031700 light absorption Effects 0.000 description 5
- 239000006166 lysate Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 210000001938 protoplast Anatomy 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- JRDYDYXZKFNNRQ-XPUUQOCRSA-N Gly-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN JRDYDYXZKFNNRQ-XPUUQOCRSA-N 0.000 description 4
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 4
- HAAQQNHQZBOWFO-LURJTMIESA-N Pro-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1 HAAQQNHQZBOWFO-LURJTMIESA-N 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 108010027668 glycyl-alanyl-valine Proteins 0.000 description 4
- 108010089804 glycyl-threonine Proteins 0.000 description 4
- 108010037850 glycylvaline Proteins 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 3
- RAQMSGVCGSJKCL-FOHZUACHSA-N Asn-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(N)=O RAQMSGVCGSJKCL-FOHZUACHSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 108010022999 Serine Proteases Proteins 0.000 description 3
- 102000012479 Serine Proteases Human genes 0.000 description 3
- XGJLNBNZNMVJRS-NRPADANISA-N Val-Glu-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O XGJLNBNZNMVJRS-NRPADANISA-N 0.000 description 3
- 102100039662 Xaa-Pro dipeptidase Human genes 0.000 description 3
- 108010005233 alanylglutamic acid Proteins 0.000 description 3
- 108010087924 alanylproline Proteins 0.000 description 3
- UTXSFKPOIVELPQ-SFHVURJKSA-N benzyl n-[2-[(2s)-2-[(4-nitrophenyl)carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]carbamate Chemical compound C1=CC([N+](=O)[O-])=CC=C1NC(=O)[C@H]1N(C(=O)CNC(=O)OCC=2C=CC=CC=2)CCC1 UTXSFKPOIVELPQ-SFHVURJKSA-N 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108010066823 proline dipeptidase Proteins 0.000 description 3
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
- 108010004914 prolylarginine Proteins 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 108010061238 threonyl-glycine Proteins 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- BRPMXFSTKXXNHF-IUCAKERBSA-N (2s)-1-[2-[[(2s)-pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H]1NCCC1 BRPMXFSTKXXNHF-IUCAKERBSA-N 0.000 description 2
- UCIYCBSJBQGDGM-LPEHRKFASA-N Ala-Arg-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N UCIYCBSJBQGDGM-LPEHRKFASA-N 0.000 description 2
- MBWYUTNBYSSUIQ-HERUPUMHSA-N Ala-Asn-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N MBWYUTNBYSSUIQ-HERUPUMHSA-N 0.000 description 2
- XQJAFSDFQZPYCU-UWJYBYFXSA-N Ala-Asn-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N XQJAFSDFQZPYCU-UWJYBYFXSA-N 0.000 description 2
- IYCZBJXFSZSHPN-DLOVCJGASA-N Ala-Cys-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O IYCZBJXFSZSHPN-DLOVCJGASA-N 0.000 description 2
- LGFCAXJBAZESCF-ACZMJKKPSA-N Ala-Gln-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O LGFCAXJBAZESCF-ACZMJKKPSA-N 0.000 description 2
- NIZKGBJVCMRDKO-KWQFWETISA-N Ala-Gly-Tyr Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NIZKGBJVCMRDKO-KWQFWETISA-N 0.000 description 2
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 2
- MFMDKJIPHSWSBM-GUBZILKMSA-N Ala-Lys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFMDKJIPHSWSBM-GUBZILKMSA-N 0.000 description 2
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 2
- HOVPGJUNRLMIOZ-CIUDSAMLSA-N Ala-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N HOVPGJUNRLMIOZ-CIUDSAMLSA-N 0.000 description 2
- SYIFFFHSXBNPMC-UWJYBYFXSA-N Ala-Ser-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N SYIFFFHSXBNPMC-UWJYBYFXSA-N 0.000 description 2
- WNHNMKOFKCHKKD-BFHQHQDPSA-N Ala-Thr-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O WNHNMKOFKCHKKD-BFHQHQDPSA-N 0.000 description 2
- SFPRJVVDZNLUTG-OWLDWWDNSA-N Ala-Trp-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SFPRJVVDZNLUTG-OWLDWWDNSA-N 0.000 description 2
- OMSKGWFGWCQFBD-KZVJFYERSA-N Ala-Val-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OMSKGWFGWCQFBD-KZVJFYERSA-N 0.000 description 2
- BQBPFMNVOWDLHO-XIRDDKMYSA-N Arg-Gln-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N BQBPFMNVOWDLHO-XIRDDKMYSA-N 0.000 description 2
- PDQBXRSOSCTGKY-ACZMJKKPSA-N Asn-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N PDQBXRSOSCTGKY-ACZMJKKPSA-N 0.000 description 2
- NUHQMYUWLUSRJX-BIIVOSGPSA-N Asn-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N NUHQMYUWLUSRJX-BIIVOSGPSA-N 0.000 description 2
- JZRLLSOWDYUKOK-SRVKXCTJSA-N Asn-Asp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N JZRLLSOWDYUKOK-SRVKXCTJSA-N 0.000 description 2
- GNKVBRYFXYWXAB-WDSKDSINSA-N Asn-Glu-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O GNKVBRYFXYWXAB-WDSKDSINSA-N 0.000 description 2
- KNMRXHIAVXHCLW-ZLUOBGJFSA-N Asp-Asn-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N)C(=O)O KNMRXHIAVXHCLW-ZLUOBGJFSA-N 0.000 description 2
- SVFOIXMRMLROHO-SRVKXCTJSA-N Asp-Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SVFOIXMRMLROHO-SRVKXCTJSA-N 0.000 description 2
- DTNUIAJCPRMNBT-WHFBIAKZSA-N Asp-Gly-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(O)=O DTNUIAJCPRMNBT-WHFBIAKZSA-N 0.000 description 2
- PGUYEUCYVNZGGV-QWRGUYRKSA-N Asp-Gly-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PGUYEUCYVNZGGV-QWRGUYRKSA-N 0.000 description 2
- LBOVBQONZJRWPV-YUMQZZPRSA-N Asp-Lys-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O LBOVBQONZJRWPV-YUMQZZPRSA-N 0.000 description 2
- KGHLGJAXYSVNJP-WHFBIAKZSA-N Asp-Ser-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O KGHLGJAXYSVNJP-WHFBIAKZSA-N 0.000 description 2
- MGSVBZIBCCKGCY-ZLUOBGJFSA-N Asp-Ser-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MGSVBZIBCCKGCY-ZLUOBGJFSA-N 0.000 description 2
- 102100037084 C4b-binding protein alpha chain Human genes 0.000 description 2
- 102400000739 Corticotropin Human genes 0.000 description 2
- 101800000414 Corticotropin Proteins 0.000 description 2
- VNLYIYOYUNGURO-ZLUOBGJFSA-N Cys-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)N VNLYIYOYUNGURO-ZLUOBGJFSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- MQANCSUBSBJNLU-KKUMJFAQSA-N Gln-Arg-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MQANCSUBSBJNLU-KKUMJFAQSA-N 0.000 description 2
- MINZLORERLNSPP-ACZMJKKPSA-N Gln-Asn-Cys Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N MINZLORERLNSPP-ACZMJKKPSA-N 0.000 description 2
- MFLMFRZBAJSGHK-ACZMJKKPSA-N Gln-Cys-Ser Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)N MFLMFRZBAJSGHK-ACZMJKKPSA-N 0.000 description 2
- LPYPANUXJGFMGV-FXQIFTODSA-N Gln-Gln-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N LPYPANUXJGFMGV-FXQIFTODSA-N 0.000 description 2
- KDXKFBSNIJYNNR-YVNDNENWSA-N Gln-Glu-Ile Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KDXKFBSNIJYNNR-YVNDNENWSA-N 0.000 description 2
- QQAPDATZKKTBIY-YUMQZZPRSA-N Gln-Gly-Met Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O QQAPDATZKKTBIY-YUMQZZPRSA-N 0.000 description 2
- MTCXQQINVAFZKW-MNXVOIDGSA-N Gln-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N MTCXQQINVAFZKW-MNXVOIDGSA-N 0.000 description 2
- OACQOWPRWGNKTP-AVGNSLFASA-N Gln-Tyr-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O OACQOWPRWGNKTP-AVGNSLFASA-N 0.000 description 2
- JKDBRTNMYXYLHO-JYJNAYRXSA-N Gln-Tyr-Leu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 JKDBRTNMYXYLHO-JYJNAYRXSA-N 0.000 description 2
- SDSMVVSHLAAOJL-UKJIMTQDSA-N Gln-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)N SDSMVVSHLAAOJL-UKJIMTQDSA-N 0.000 description 2
- QBLCUWAGTGRXAY-UHFFFAOYSA-N Glu-Glu-Tyr-Tyr Chemical compound C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(NC(=O)C(CCC(O)=O)NC(=O)C(CCC(O)=O)N)CC1=CC=C(O)C=C1 QBLCUWAGTGRXAY-UHFFFAOYSA-N 0.000 description 2
- HILMIYALTUQTRC-XVKPBYJWSA-N Glu-Gly-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O HILMIYALTUQTRC-XVKPBYJWSA-N 0.000 description 2
- BRKUZSLQMPNVFN-SRVKXCTJSA-N Glu-His-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O BRKUZSLQMPNVFN-SRVKXCTJSA-N 0.000 description 2
- BIHMNDPWRUROFZ-JYJNAYRXSA-N Glu-His-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O BIHMNDPWRUROFZ-JYJNAYRXSA-N 0.000 description 2
- LPHGXOWFAXFCPX-KKUMJFAQSA-N Glu-Pro-Phe Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O LPHGXOWFAXFCPX-KKUMJFAQSA-N 0.000 description 2
- NNQDRRUXFJYCCJ-NHCYSSNCSA-N Glu-Pro-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O NNQDRRUXFJYCCJ-NHCYSSNCSA-N 0.000 description 2
- DMYACXMQUABZIQ-NRPADANISA-N Glu-Ser-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O DMYACXMQUABZIQ-NRPADANISA-N 0.000 description 2
- JVYNYWXHZWVJEF-NUMRIWBASA-N Glu-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O JVYNYWXHZWVJEF-NUMRIWBASA-N 0.000 description 2
- YQAQQKPWFOBSMU-WDCWCFNPSA-N Glu-Thr-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O YQAQQKPWFOBSMU-WDCWCFNPSA-N 0.000 description 2
- JLCYOCDGIUZMKQ-JBACZVJFSA-N Glu-Trp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCC(=O)O)N JLCYOCDGIUZMKQ-JBACZVJFSA-N 0.000 description 2
- MIWJDJAMMKHUAR-ZVZYQTTQSA-N Glu-Trp-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)O)N MIWJDJAMMKHUAR-ZVZYQTTQSA-N 0.000 description 2
- ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 2
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 2
- ULZCYBYDTUMHNF-IUCAKERBSA-N Gly-Leu-Glu Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ULZCYBYDTUMHNF-IUCAKERBSA-N 0.000 description 2
- GBYYQVBXFVDJPJ-WLTAIBSBSA-N Gly-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)CN)O GBYYQVBXFVDJPJ-WLTAIBSBSA-N 0.000 description 2
- JYGYNWYVKXENNE-OALUTQOASA-N Gly-Tyr-Trp Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O JYGYNWYVKXENNE-OALUTQOASA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- OBTMRGFRLJBSFI-GARJFASQSA-N His-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O OBTMRGFRLJBSFI-GARJFASQSA-N 0.000 description 2
- BBQABUDWDUKJMB-LZXPERKUSA-N Ile-Ile-Ile Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C([O-])=O BBQABUDWDUKJMB-LZXPERKUSA-N 0.000 description 2
- OMDWJWGZGMCQND-CFMVVWHZSA-N Ile-Tyr-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N OMDWJWGZGMCQND-CFMVVWHZSA-N 0.000 description 2
- RQZFWBLDTBDEOF-RNJOBUHISA-N Ile-Val-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N RQZFWBLDTBDEOF-RNJOBUHISA-N 0.000 description 2
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 2
- WUFYAPWIHCUMLL-CIUDSAMLSA-N Leu-Asn-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O WUFYAPWIHCUMLL-CIUDSAMLSA-N 0.000 description 2
- ZDSNOSQHMJBRQN-SRVKXCTJSA-N Leu-Asp-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ZDSNOSQHMJBRQN-SRVKXCTJSA-N 0.000 description 2
- DKEZVKFLETVJFY-CIUDSAMLSA-N Leu-Cys-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)O)N DKEZVKFLETVJFY-CIUDSAMLSA-N 0.000 description 2
- TVEOVCYCYGKVPP-HSCHXYMDSA-N Leu-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(C)C)N TVEOVCYCYGKVPP-HSCHXYMDSA-N 0.000 description 2
- HVHRPWQEQHIQJF-AVGNSLFASA-N Leu-Lys-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HVHRPWQEQHIQJF-AVGNSLFASA-N 0.000 description 2
- YWKNKRAKOCLOLH-OEAJRASXSA-N Leu-Phe-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=CC=C1 YWKNKRAKOCLOLH-OEAJRASXSA-N 0.000 description 2
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 2
- RDFIVFHPOSOXMW-ACRUOGEOSA-N Leu-Tyr-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RDFIVFHPOSOXMW-ACRUOGEOSA-N 0.000 description 2
- FDBTVENULFNTAL-XQQFMLRXSA-N Leu-Val-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N FDBTVENULFNTAL-XQQFMLRXSA-N 0.000 description 2
- VKVDRTGWLVZJOM-DCAQKATOSA-N Leu-Val-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O VKVDRTGWLVZJOM-DCAQKATOSA-N 0.000 description 2
- KCXUCYYZNZFGLL-SRVKXCTJSA-N Lys-Ala-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O KCXUCYYZNZFGLL-SRVKXCTJSA-N 0.000 description 2
- DGWXCIORNLWGGG-CIUDSAMLSA-N Lys-Asn-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O DGWXCIORNLWGGG-CIUDSAMLSA-N 0.000 description 2
- YSPZCHGIWAQVKQ-AVGNSLFASA-N Lys-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN YSPZCHGIWAQVKQ-AVGNSLFASA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- VHGIWFGJIHTASW-FXQIFTODSA-N Met-Ala-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O VHGIWFGJIHTASW-FXQIFTODSA-N 0.000 description 2
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 239000008118 PEG 6000 Substances 0.000 description 2
- CDNPIRSCAFMMBE-SRVKXCTJSA-N Phe-Asn-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O CDNPIRSCAFMMBE-SRVKXCTJSA-N 0.000 description 2
- GDBOREPXIRKSEQ-FHWLQOOXSA-N Phe-Gln-Phe Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O GDBOREPXIRKSEQ-FHWLQOOXSA-N 0.000 description 2
- CDQCFGOQNYOICK-IHRRRGAJSA-N Phe-Glu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 CDQCFGOQNYOICK-IHRRRGAJSA-N 0.000 description 2
- APJPXSFJBMMOLW-KBPBESRZSA-N Phe-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 APJPXSFJBMMOLW-KBPBESRZSA-N 0.000 description 2
- HQCSLJFGZYOXHW-KKUMJFAQSA-N Phe-His-Cys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CS)C(=O)O)N HQCSLJFGZYOXHW-KKUMJFAQSA-N 0.000 description 2
- UMIHVJQSXFWWMW-JBACZVJFSA-N Phe-Trp-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N UMIHVJQSXFWWMW-JBACZVJFSA-N 0.000 description 2
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 2
- XROLYVMNVIKVEM-BQBZGAKWSA-N Pro-Asn-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O XROLYVMNVIKVEM-BQBZGAKWSA-N 0.000 description 2
- DEDANIDYQAPTFI-IHRRRGAJSA-N Pro-Asp-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O DEDANIDYQAPTFI-IHRRRGAJSA-N 0.000 description 2
- NMELOOXSGDRBRU-YUMQZZPRSA-N Pro-Glu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1 NMELOOXSGDRBRU-YUMQZZPRSA-N 0.000 description 2
- VYWNORHENYEQDW-YUMQZZPRSA-N Pro-Gly-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 VYWNORHENYEQDW-YUMQZZPRSA-N 0.000 description 2
- DXTOOBDIIAJZBJ-BQBZGAKWSA-N Pro-Gly-Ser Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(O)=O DXTOOBDIIAJZBJ-BQBZGAKWSA-N 0.000 description 2
- AFXCXDQNRXTSBD-FJXKBIBVSA-N Pro-Gly-Thr Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O AFXCXDQNRXTSBD-FJXKBIBVSA-N 0.000 description 2
- BWCZJGJKOFUUCN-ZPFDUUQYSA-N Pro-Ile-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O BWCZJGJKOFUUCN-ZPFDUUQYSA-N 0.000 description 2
- RYJRPPUATSKNAY-STECZYCISA-N Pro-Ile-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@@H]2CCCN2 RYJRPPUATSKNAY-STECZYCISA-N 0.000 description 2
- FMLRRBDLBJLJIK-DCAQKATOSA-N Pro-Leu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FMLRRBDLBJLJIK-DCAQKATOSA-N 0.000 description 2
- XNJVJEHDZPDPQL-BZSNNMDCSA-N Pro-Trp-Arg Chemical compound NC(=N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1)C(O)=O XNJVJEHDZPDPQL-BZSNNMDCSA-N 0.000 description 2
- YHUBAXGAAYULJY-ULQDDVLXSA-N Pro-Tyr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O YHUBAXGAAYULJY-ULQDDVLXSA-N 0.000 description 2
- OOZJHTXCLJUODH-QXEWZRGKSA-N Pro-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 OOZJHTXCLJUODH-QXEWZRGKSA-N 0.000 description 2
- 101710136733 Proline-rich protein Proteins 0.000 description 2
- 102000056251 Prolyl Oligopeptidases Human genes 0.000 description 2
- BGOWRLSWJCVYAQ-CIUDSAMLSA-N Ser-Asp-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BGOWRLSWJCVYAQ-CIUDSAMLSA-N 0.000 description 2
- PPNPDKGQRFSCAC-CIUDSAMLSA-N Ser-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPNPDKGQRFSCAC-CIUDSAMLSA-N 0.000 description 2
- ILZAUMFXKSIUEF-SRVKXCTJSA-N Ser-Ser-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ILZAUMFXKSIUEF-SRVKXCTJSA-N 0.000 description 2
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 2
- NERYDXBVARJIQS-JYBASQMISA-N Ser-Trp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)N)O NERYDXBVARJIQS-JYBASQMISA-N 0.000 description 2
- PQEQXWRVHQAAKS-SRVKXCTJSA-N Ser-Tyr-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC1=CC=C(O)C=C1 PQEQXWRVHQAAKS-SRVKXCTJSA-N 0.000 description 2
- JZRYFUGREMECBH-XPUUQOCRSA-N Ser-Val-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O JZRYFUGREMECBH-XPUUQOCRSA-N 0.000 description 2
- CEXFELBFVHLYDZ-XGEHTFHBSA-N Thr-Arg-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O CEXFELBFVHLYDZ-XGEHTFHBSA-N 0.000 description 2
- TZKPNGDGUVREEB-FOHZUACHSA-N Thr-Asn-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O TZKPNGDGUVREEB-FOHZUACHSA-N 0.000 description 2
- YBXMGKCLOPDEKA-NUMRIWBASA-N Thr-Asp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YBXMGKCLOPDEKA-NUMRIWBASA-N 0.000 description 2
- XDARBNMYXKUFOJ-GSSVUCPTSA-N Thr-Asp-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XDARBNMYXKUFOJ-GSSVUCPTSA-N 0.000 description 2
- LKEKWDJCJSPXNI-IRIUXVKKSA-N Thr-Glu-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 LKEKWDJCJSPXNI-IRIUXVKKSA-N 0.000 description 2
- ADPHPKGWVDHWML-PPCPHDFISA-N Thr-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N ADPHPKGWVDHWML-PPCPHDFISA-N 0.000 description 2
- RRRRCRYTLZVCEN-HJGDQZAQSA-N Thr-Leu-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O RRRRCRYTLZVCEN-HJGDQZAQSA-N 0.000 description 2
- WRQLCVIALDUQEQ-UNQGMJICSA-N Thr-Phe-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WRQLCVIALDUQEQ-UNQGMJICSA-N 0.000 description 2
- ABWNZPOIUJMNKT-IXOXFDKPSA-N Thr-Phe-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O ABWNZPOIUJMNKT-IXOXFDKPSA-N 0.000 description 2
- RVMNUBQWPVOUKH-HEIBUPTGSA-N Thr-Ser-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMNUBQWPVOUKH-HEIBUPTGSA-N 0.000 description 2
- BKIOKSLLAAZYTC-KKHAAJSZSA-N Thr-Val-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O BKIOKSLLAAZYTC-KKHAAJSZSA-N 0.000 description 2
- XZLHHHYSWIYXHD-XIRDDKMYSA-N Trp-Gln-Arg Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O XZLHHHYSWIYXHD-XIRDDKMYSA-N 0.000 description 2
- OBWQLWYNNZPWGX-QEJZJMRPSA-N Trp-Gln-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O OBWQLWYNNZPWGX-QEJZJMRPSA-N 0.000 description 2
- JVTHMUDOKPQBOT-NSHDSACASA-N Trp-Gly-Gly Chemical compound C1=CC=C2C(C[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O)=CNC2=C1 JVTHMUDOKPQBOT-NSHDSACASA-N 0.000 description 2
- HIZDHWHVOLUGOX-BPUTZDHNSA-N Trp-Ser-Val Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O HIZDHWHVOLUGOX-BPUTZDHNSA-N 0.000 description 2
- YCEHCFIOIYNQTR-NYVOZVTQSA-N Trp-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CO)C(=O)O)N YCEHCFIOIYNQTR-NYVOZVTQSA-N 0.000 description 2
- KPEVFMGKBCMTJF-SZMVWBNQSA-N Trp-Val-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N KPEVFMGKBCMTJF-SZMVWBNQSA-N 0.000 description 2
- UNUZEBFXGWVAOP-DZKIICNBSA-N Tyr-Glu-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UNUZEBFXGWVAOP-DZKIICNBSA-N 0.000 description 2
- AZGZDDNKFFUDEH-QWRGUYRKSA-N Tyr-Gly-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AZGZDDNKFFUDEH-QWRGUYRKSA-N 0.000 description 2
- DMWNPLOERDAHSY-MEYUZBJRSA-N Tyr-Leu-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DMWNPLOERDAHSY-MEYUZBJRSA-N 0.000 description 2
- PHKQVWWHRYUCJL-HJOGWXRNSA-N Tyr-Phe-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O PHKQVWWHRYUCJL-HJOGWXRNSA-N 0.000 description 2
- ZPFLBLFITJCBTP-QWRGUYRKSA-N Tyr-Ser-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)NCC(O)=O ZPFLBLFITJCBTP-QWRGUYRKSA-N 0.000 description 2
- HMPMGPISLMLHSI-JBACZVJFSA-N Tyr-Trp-Gln Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N HMPMGPISLMLHSI-JBACZVJFSA-N 0.000 description 2
- NUQZCPSZHGIYTA-HKUYNNGSSA-N Tyr-Trp-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N NUQZCPSZHGIYTA-HKUYNNGSSA-N 0.000 description 2
- MWUYSCVVPVITMW-IGNZVWTISA-N Tyr-Tyr-Ala Chemical compound C([C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 MWUYSCVVPVITMW-IGNZVWTISA-N 0.000 description 2
- SQUMHUZLJDUROQ-YDHLFZDLSA-N Tyr-Val-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O SQUMHUZLJDUROQ-YDHLFZDLSA-N 0.000 description 2
- YFOCMOVJBQDBCE-NRPADANISA-N Val-Ala-Glu Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N YFOCMOVJBQDBCE-NRPADANISA-N 0.000 description 2
- CGGVNFJRZJUVAE-BYULHYEWSA-N Val-Asp-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CGGVNFJRZJUVAE-BYULHYEWSA-N 0.000 description 2
- VVZDBPBZHLQPPB-XVKPBYJWSA-N Val-Glu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VVZDBPBZHLQPPB-XVKPBYJWSA-N 0.000 description 2
- SYOMXKPPFZRELL-ONGXEEELSA-N Val-Gly-Lys Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N SYOMXKPPFZRELL-ONGXEEELSA-N 0.000 description 2
- YMTOEGGOCHVGEH-IHRRRGAJSA-N Val-Lys-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O YMTOEGGOCHVGEH-IHRRRGAJSA-N 0.000 description 2
- DEGUERSKQBRZMZ-FXQIFTODSA-N Val-Ser-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DEGUERSKQBRZMZ-FXQIFTODSA-N 0.000 description 2
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 2
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 2
- QPJSIBAOZBVELU-BPNCWPANSA-N Val-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N QPJSIBAOZBVELU-BPNCWPANSA-N 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 108010008355 arginyl-glutamine Proteins 0.000 description 2
- 108010060035 arginylproline Proteins 0.000 description 2
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 2
- 108010093581 aspartyl-proline Proteins 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 2
- 229960000258 corticotropin Drugs 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 108010049041 glutamylalanine Proteins 0.000 description 2
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 2
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 2
- 108010051307 glycyl-glycyl-proline Proteins 0.000 description 2
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 2
- 108010010147 glycylglutamine Proteins 0.000 description 2
- 108010077515 glycylproline Proteins 0.000 description 2
- 108010028295 histidylhistidine Proteins 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 108010076718 lysyl-glutamyl-tryptophan Proteins 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 2
- 239000000813 peptide hormone Substances 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 108010024607 phenylalanylalanine Proteins 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108010020755 prolyl-glycyl-glycine Proteins 0.000 description 2
- 108010014614 prolyl-glycyl-proline Proteins 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000004153 renaturation Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 108010058119 tryptophyl-glycyl-glycine Proteins 0.000 description 2
- 108010020532 tyrosyl-proline Proteins 0.000 description 2
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 1
- TZDNWXDLYFIFPT-BJDJZHNGSA-N Ala-Ile-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O TZDNWXDLYFIFPT-BJDJZHNGSA-N 0.000 description 1
- KUFVXLQLDHJVOG-SHGPDSBTSA-N Ala-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C)N)O KUFVXLQLDHJVOG-SHGPDSBTSA-N 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- ZTKHZAXGTFXUDD-VEVYYDQMSA-N Arg-Asn-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZTKHZAXGTFXUDD-VEVYYDQMSA-N 0.000 description 1
- GFFRWIJAFFMQGM-NUMRIWBASA-N Asn-Glu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GFFRWIJAFFMQGM-NUMRIWBASA-N 0.000 description 1
- UXHYOWXTJLBEPG-GSSVUCPTSA-N Asn-Thr-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UXHYOWXTJLBEPG-GSSVUCPTSA-N 0.000 description 1
- ORRJQLIATJDMQM-HJGDQZAQSA-N Asp-Leu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O ORRJQLIATJDMQM-HJGDQZAQSA-N 0.000 description 1
- LKVKODXGSAFOFY-VEVYYDQMSA-N Asp-Met-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LKVKODXGSAFOFY-VEVYYDQMSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000005572 Cathepsin A Human genes 0.000 description 1
- 108010059081 Cathepsin A Proteins 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 101150047844 F1 gene Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102400000921 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- DLISPGXMKZTWQG-IFFSRLJSSA-N Glu-Thr-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O DLISPGXMKZTWQG-IFFSRLJSSA-N 0.000 description 1
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 1
- HQRHFUYMGCHHJS-LURJTMIESA-N Gly-Gly-Arg Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N HQRHFUYMGCHHJS-LURJTMIESA-N 0.000 description 1
- UPADCCSMVOQAGF-LBPRGKRZSA-N Gly-Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CNC(=O)CN)C(O)=O)=CNC2=C1 UPADCCSMVOQAGF-LBPRGKRZSA-N 0.000 description 1
- AWASVTXPTOLPPP-MBLNEYKQSA-N His-Ala-Thr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AWASVTXPTOLPPP-MBLNEYKQSA-N 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- GLBNEGIOFRVRHO-JYJNAYRXSA-N Leu-Gln-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O GLBNEGIOFRVRHO-JYJNAYRXSA-N 0.000 description 1
- HGLKOTPFWOMPOB-MEYUZBJRSA-N Leu-Thr-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HGLKOTPFWOMPOB-MEYUZBJRSA-N 0.000 description 1
- ONPDTSFZAIWMDI-AVGNSLFASA-N Lys-Leu-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ONPDTSFZAIWMDI-AVGNSLFASA-N 0.000 description 1
- HKXSZKJMDBHOTG-CIUDSAMLSA-N Lys-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN HKXSZKJMDBHOTG-CIUDSAMLSA-N 0.000 description 1
- KSIPKXNIQOWMIC-RCWTZXSCSA-N Met-Thr-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCNC(N)=N KSIPKXNIQOWMIC-RCWTZXSCSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 102400000050 Oxytocin Human genes 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 238000013494 PH determination Methods 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- CYZBFPYMSJGBRL-DRZSPHRISA-N Phe-Ala-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CYZBFPYMSJGBRL-DRZSPHRISA-N 0.000 description 1
- BPIFSOUEUYDJRM-DCPHZVHLSA-N Phe-Trp-Ala Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C)C(O)=O)C1=CC=CC=C1 BPIFSOUEUYDJRM-DCPHZVHLSA-N 0.000 description 1
- XQLBWXHVZVBNJM-FXQIFTODSA-N Pro-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 XQLBWXHVZVBNJM-FXQIFTODSA-N 0.000 description 1
- HMNSRTLZAJHSIK-YUMQZZPRSA-N Pro-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 HMNSRTLZAJHSIK-YUMQZZPRSA-N 0.000 description 1
- ICTZKEXYDDZZFP-SRVKXCTJSA-N Pro-Arg-Pro Chemical compound N([C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(O)=O)C(=O)[C@@H]1CCCN1 ICTZKEXYDDZZFP-SRVKXCTJSA-N 0.000 description 1
- IMNVAOPEMFDAQD-NHCYSSNCSA-N Pro-Val-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IMNVAOPEMFDAQD-NHCYSSNCSA-N 0.000 description 1
- 108700015930 Prolyl Oligopeptidases Proteins 0.000 description 1
- 102100037838 Prolyl endopeptidase Human genes 0.000 description 1
- 101710178372 Prolyl endopeptidase Proteins 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- BRKHVZNDAOMAHX-BIIVOSGPSA-N Ser-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N BRKHVZNDAOMAHX-BIIVOSGPSA-N 0.000 description 1
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- AQAMPXBRJJWPNI-JHEQGTHGSA-N Thr-Gly-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AQAMPXBRJJWPNI-JHEQGTHGSA-N 0.000 description 1
- FWTFAZKJORVTIR-VZFHVOOUSA-N Thr-Ser-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O FWTFAZKJORVTIR-VZFHVOOUSA-N 0.000 description 1
- PWONLXBUSVIZPH-RHYQMDGZSA-N Thr-Val-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O PWONLXBUSVIZPH-RHYQMDGZSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- NIWAGRRZHCMPOY-GMVOTWDCSA-N Trp-Ala-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N NIWAGRRZHCMPOY-GMVOTWDCSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- KEANSLVUGJADPN-LKTVYLICSA-N Tyr-His-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CC=C(C=C2)O)N KEANSLVUGJADPN-LKTVYLICSA-N 0.000 description 1
- WTTRJMAZPDHPGS-KKXDTOCCSA-N Tyr-Phe-Ala Chemical compound C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O WTTRJMAZPDHPGS-KKXDTOCCSA-N 0.000 description 1
- 102400000757 Ubiquitin Human genes 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- AGXGCFSECFQMKB-NHCYSSNCSA-N Val-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N AGXGCFSECFQMKB-NHCYSSNCSA-N 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Substances OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- 108010083476 phenylalanyltryptophan Proteins 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000000734 protein sequencing Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
- C12N9/62—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from Aspergillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C5/00—Other raw materials for the preparation of beer
- C12C5/004—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21026—Prolyl oligopeptidase (3.4.21.26), i.e. proline-specific endopeptidase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to the technical field of genetic engineering, and particularly relates to a proline protease mutant and application thereof. The proline protease mutant obtained by screening through the directed evolution technology has the optimal reaction pH value of 4.0 and the optimal reaction temperature of 55 ℃, can keep more than 80% of enzyme activity within the range of 45-60 ℃, and has heat resistance obviously higher than that of a wild type. The mutant can be widely applied to beer production, and can obviously reduce the turbidity of beer.
Description
Technical Field
The invention belongs to the technical field of genetic engineering, and particularly relates to application of prolinase mutants.
Technical Field
Prolinases, also known as prolyl endopeptidases (PEP for short) or prolyl oligopeptidases, belong to a new family of serine proteases which specifically hydrolyse the carboxy-terminal peptide bond of proline residues in polypeptides, contain the highly conserved sequence of G-X-S-X-G/a of the classical serine protease family, but the amino acid residues around the active site Ser are different from other classical serine proteins and have a very low homology in the primary structure compared to the known serine protease families (including trypsin, subtilisin, carboxypeptidase Y).
Prolinases are capable of degrading not only oxytocin but also many oxytocin analogues, and the degradation of antidiuretic hormones is also due to cleavage of the carboxy terminal peptide bond of proline. In addition, many peptide hormones are also inactivated by cleavage of the carboxy-terminal peptide bond of the proline residue in the same manner. In contrast, gastrin, corticotropin and guinea pig collagen in humans are not degraded by these enzymes, nor are prolinases capable of degrading many of the higher molecular weight proteins and polypeptides, such as serum proteins, IgG, elastin, gelatin, casein, adrenocorticotropic hormone releasing hormone, ubiquitin and protease inhibitors. According to analysis of various peptide hormones and artificially synthesized polypeptides degraded by proline protease, the proline protease from different sources can specifically degrade cis-structure Pro-Y ' bonds in Y-Pro-Y ' in a peptide chain, and Y ' can be amino acids, polypeptides, amides, aromatic amines or alcohol compounds except proline.
In the food and fermentation industries, prolyl proteases are valuable enzymes, such as enzymes that increase the non-biological stability of beer by hydrolyzing proline-rich protein polypeptides in beer, preventing them from forming large polymer-turbid precipitates with polyphenols. It has been reported that prolinases demonstrate a debittering effect in protein hydrolysates. In addition, in view of the specificity of prolinases, the prolinases are also possible as a tool enzyme in molecular biology, and are used for protein sequencing, site-specific cleavage, modification and processing of peptide fragments, and the like.
Prolinases, a very important industrial enzyme, are currently used mainly in the food processing industry and in the brewery industry, and are particularly prominent in the beer production and bread making industry. The prolease can degrade proline of turbid sensitive protein in beer to inactivate the proline, and remarkably improves the non-biological stability of the beer on the premise of not influencing the fermentation performance.
In industrial production, the great significance of seeking the enzyme with the maximum expression quantity of the microorganism and improving the specific property of the enzyme is achieved, so that the production cost can be obviously reduced, and the energy consumption and the environmental pollution can be reduced. In general, in addition to the improvement of microbial expression levels by conventional strain mutagenesis methods, the performance and expression levels can be modified by genetic engineering means such as mutation, use of strong promoters, multiple copies of genes, appropriate signal peptides, and the like. Therefore, it is a research hotspot in the field to obtain prolease with excellent performance by screening or modifying methods.
Disclosure of Invention
The invention provides a novel prolease mutant and application thereof for solving the problems of the prior art. The mutant is obtained by screening through directed evolution technology, the heat resistance of the mutant is obviously higher than that of a wild type, and the wide application of prolinase is facilitated.
The invention provides proline protease with an amino acid sequence of SEQ ID NO. 1.
The nucleotide sequence of the prolease coding gene is SEQ ID NO. 2.
In another aspect, the present invention provides a proline protease mutant, which is prolinase having an amino acid sequence of SEQ ID NO. 1, wherein the 101 th amino acid is changed from Gly to Glu, the 146 th amino acid is changed from Val to Ile, and the 441 th amino acid is changed from Arg to Trp.
The amino acid sequence of the prolease mutant is SEQ ID NO. 3, and the nucleic acid sequence of the coding gene is SEQ ID NO: 4.
in another aspect of the present invention, a recombinant plasmid is provided, which carries a nucleic acid sequence having the coding sequence of SEQ ID NO: 4 in the presence of a protease inhibitor.
The present invention also provides a recombinant strain obtained by transforming the above recombinant plasmid into Aspergillus niger.
The invention also provides the application of the prolin mutant in the production of beer or beverage.
The proline protease mutant obtained by screening through the directed evolution technology has the optimal reaction pH value of 4.0 and the optimal reaction temperature of 55 ℃, can keep more than 80% of enzyme activity within the range of 45-60 ℃, and has heat resistance obviously higher than that of a wild type. The mutant can be widely applied to beer production, and can obviously reduce the turbidity of beer. The mutant can be added in the wort preparation process, and the reduction of the wort turbidity is improved by 29.4-48.3% compared with the experiment group 1 in which the wild-type prolease with the same dosage is added; the mutant may also be added during beer fermentation, where the turbidity reduction of the beer is increased by 8.9-15.4% compared to test group 1, where the same amount of wild-type prolinase was added. Therefore, the prolease mutant provided by the invention can better tolerate high temperature in the wort saccharification process, and the enzymolysis effect on sensitive protein in the fermentation process is obviously better than that of wild prolease, so that the prolease mutant is more favorable for reducing turbidity caused by the sensitive protein, and obtains unexpected effect.
Drawings
FIG. 1 is a map of plasmid pSU;
FIG. 2 is a comparison of the optimal reaction temperatures of the prolease F1 and its mutant F2;
FIG. 3 shows pH optimum reaction comparisons of prolease F1 and its mutant F2.
Detailed Description
The present invention uses conventional techniques and methods used IN the fields of genetic engineering and MOLECULAR BIOLOGY, such as those described IN MOLECULAR CLONING, ALABORATORY MANUAL,3nd Ed. (Sambrook,2001) and CURRENTPROTORCOLS IN MOLECULAR BIOLOGY (Ausubel, 2003). These general references provide definitions and methods known to those skilled in the art. However, those skilled in the art can adopt other conventional methods, experimental schemes and reagents in the field on the basis of the technical scheme described in the invention, and the invention is not limited to the specific embodiment of the invention.
The present invention will be described in detail with reference to specific embodiments.
Example 1 preparation of prolinase Gene
The genome of a strain of Aspergillus niger Su2-1 stored in this laboratory was extracted. PCR amplification was performed using the following primer F and primer R. The reaction conditions are as follows: denaturation at 94 deg.C for 5 min; then denaturation at 94 ℃ for 30s, renaturation at 56 ℃ for 30s, extension at 72 ℃ for 120s, and after 30 cycles, heat preservation at 72 ℃ for 10 min. And (3) carrying out agarose electrophoresis on the amplification product, wherein the result shows that the size of the gene fragment obtained by amplification is 2100 bp.
And (3) primer F: ATGCGTTCCTTCTCCGCTGTCG
And (3) primer R: TCAAGCATAATACTCCTCCACC
The obtained gene fragment is sent to Shanghai biological engineering Co., Ltd to complete sequencing. The sequencing result shows that the nucleotide sequence of the gene fragment is SEQ ID NO:2, the encoded amino acid sequence is SEQ ID NO: 1. the protein coded by the gene is found to be proline protease by NCBIBLAST comparison and is named F1.
Example 2 obtaining of prolinase mutants
In order to improve the thermostability of the prolease F1, the present applicant screened the enzyme for a large number of mutations by directed evolution.
Using F1 gene as a template, using a primer F and a primer R to perform PCR amplification by using a GeneMorph II random mutation PCR kit (Stratagene), recovering PCR products by using gelatin, performing enzyme digestion treatment on EcoRI and NotI, connecting the PCR products with pET21a vectors subjected to the same enzyme digestion, transforming the PCR products into escherichia coli BL21(DE3), coating the escherichia coli BL21 into an LB + Amp plate, performing inversion culture at 37 ℃, selecting transformants one by using toothpicks to a 96-well plate, adding 150ul LB + Amp culture medium containing 0.1mM IPTG into each well, performing culture at 220rpm at 37 ℃ for about 6h, centrifuging, discarding supernatant, using buffer solution with pH5.5 for thalli, repeatedly performing freeze thawing and wall breaking, and obtaining the escherichia coli cell lysate containing prolease F1.
And respectively taking out 30 mu l of lysate to two new 96-well plates, treating one of the lysates at 50 ℃ for 10min, diluting the lysate to a buffer solution with pH5.5, and diluting the lysate to a buffer solution with pH5.5 without treatment to respectively measure the enzyme activity of the lysate.
As a result, it was found that different mutants maintained different enzyme activities after high temperature treatment, some of the mutations had no effect on prolinases activity, and some of the mutations even reduced their activity, and DNA sequencing was performed on mutants still maintaining high activities. Finally, the applicant obtained three point mutants capable of significantly improving the thermotolerance of the prolease F1: G101E, V146I and R441W.
The proline protease mutant containing three point mutations of G101E, V146I and R441W is named as F2, and the amino acid sequence of the proline protease mutant is SEQ ID NO:3, obtaining a coding nucleotide sequence of SEQ ID NO: 4.
the prolease mutant gene was PCR-amplified with primers F, R, EcoRI and Not I sites were introduced at both ends of the primers. The PCR reaction conditions are as follows: denaturation at 94 deg.C for 5 min; then denaturation at 94 ℃ for 30s, renaturation at 56 ℃ for 30s, extension at 72 ℃ for 120s, and after 30 cycles, heat preservation at 72 ℃ for 10 min. The agarose gel electrophoresis result showed that the size of the proline protease mutant F2 was about 2100 bp.
EXAMPLE 3 construction of recombinant expression vectors
Prolidase F1 and mutant F2 genes thereof are connected to an expression vector pSU (shown in figure 1) through XbaI respectively to construct expression vectors pSU-F1 and pSU-F2.
Preparing protoplasts: inoculating host bacterium Aspergillus niger Su2-1 to PDA + U plate, and culturing at 30 deg.C for 5-7 d. The mycelia with the size of 2cm multiplied by 2cm are cut and inoculated into 100ml of liquid PDA + U culture medium, and cultured at 30 ℃ for 24h to grow mycelia for transformation. After the grown mycelia were filtered, it was resuspended in 20ml of 1.2M magnesium sulfate solution, and 0.2g of lysozyme was added. Culturing at 30 deg.C and 100rpm for 2-3 h. Filtering the lysed mycelia with 2 layers of mirror paper, and centrifuging at 3000rpm for 10min to obtain protoplast.
And (3) transformation: the protoplast was washed 2 times with 1.2M sorbitol solution and resuspended in an appropriate amount of sorbitol solution to a protoplast concentration of 108. 200ul protoplast was added with 10ul of the prepared plasmid, 50ul of 25% PEG6000 was added, ice-cooled for 20min, then 2ml of 25% PEG6000 was added, and the mixture was left at room temperature for 5min, and then 4ml of sorbitol solution was added and mixed by inversion. After 50ml of the transformation supernatant medium was poured, the mixture was poured into 4 transformation bottom plates, and after the supernatant medium solidified, the plate was cultured in an incubator at 30 ℃ for 5 days in an inverted manner.
And (3) transformant screening: after 5 days of culture, the grown colonies are picked up, spotted on a transformation lower layer plate for re-screening, and cultured for 2 days at 30 ℃. The transformants which grew normally were inoculated into fresh PDA plates, respectively, and cultured at 30 ℃ for 5-7 days. Each transformant is cut into 2cm multiplied by 2cm fungus blocks, inoculated into 50ml liquid shake flask culture medium respectively for fermentation, cultured for 5 days at 32 ℃, added with proper amount of ammonia water every day, and the pH is controlled to be about 4.5. After culturing for 5 days, centrifuging the thallus to obtain supernatant, namely crude enzyme liquid. And (3) carrying out protein electrophoresis detection on the crude enzyme solution to screen out a transformant with obvious protein band expression.
The applicant named Aspergillus niger Su-F1(Aspergillus niger Su-F1) for one of the screened positive transformants recombinantly expressing prolidase mutant F1 and Aspergillus niger Su-F2(Aspergillus niger Su-F2).
And (3) carrying out prolinase activity detection on fermentation supernatants of the Aspergillus niger Su-F1 and the Aspergillus niger Su-F2, and taking the fermentation supernatant of the Aspergillus niger host bacteria as a control. The results show that: the enzyme activity of the fermentation supernatant of the Aspergillus niger host bacteria is only 3.2U/ml, while the enzyme activities of the fermentation supernatants of the Aspergillus niger Su-F1 and the Aspergillus niger Su-F2 are respectively 30.5U/ml and 35.4U/ml. Therefore, the recombinant bacteria Aspergillus niger Su-F1 and Aspergillus niger Su-F2 constructed by the invention can respectively express prolinase F1 and mutant F2 in a recombinant mode.
Enzyme activity measuring method
(1) Definition of the Prolin enzyme Activity Unit
The enzyme amount of 1. mu. molpNA released by decomposing Z-GLY-Pro-pNA per minute at 37 ℃ and pH5.0 was defined as one enzyme activity unit U.
(2) Enzyme activity measuring method
Reagent: disodium hydrogen phosphate (0.2mol/L) -citric acid (0.1mol/L) buffer solution with pH of 5.0
Z-GLY-Pro-pNA solution (5mmol/L)
1ml of Z-GLY-Pro-pNA solution with the concentration of 5mmol/L is uniformly mixed in 10ml of phosphoric acid-citric acid buffer solution, and the mixture is prepared 10min before the sample measurement and can be used for 4 h.
Adding 1.1ml of the substrate mixture into a test tube;
preheating the test tube in a water bath at 37 deg.C for 15 min;
placing a cuvette (0.5cm) on a cuvette frame, adjusting the temperature of the cuvette frame to 37 ℃, and adjusting a spectrophotometer to 410nm to measure absorbance;
0.1ml of diluted enzyme solution is absorbed and added into a test tube containing substrate mixed solution, timing is started when the enzyme solution is added, and the diluted enzyme solution is poured into a cuvette after vortex mixing;
after the cuvette was placed on the cuvette holder, the data for 30s were read;
when the enzyme solution reacts, if the light absorption value has a trend of descending and ascending, recording the light absorption value and time of descending to the valley bottom, and continuously recording data after 10 min;
if the light absorption value does not decrease, the light absorption values at 410nm before and after the reaction can be directly recorded, and the reaction time is 10 min.
Prolidase activity was calculated by Δ a 410:
U=(ΔA410×V×1000×1000×N)/(T×γ×ν×β)
wherein: Δ A410: the change of the light absorption value;
t: reaction time (10 min);
v: reaction system volume (1.2 ml);
1000X 1000: converting the mol into mu mol;
γ: molar extinction coefficient (cm)2/mol)8800;
β optical path length of cuvette (0.5 cm);
v: sample size (0.1 ml);
n: dilution times;
example 4 analysis of enzymatic Properties
1. Determination of optimum reaction temperature
The prolinase activities of the crude enzyme solutions fermented by the recombinant strains Aspergillus niger Su-F1 and Aspergillus niger Su-F2 obtained in example 3 were measured at 30 ℃, 35 ℃, 40 ℃, 45 ℃, 50 ℃, 55 ℃, 60 ℃, 65 ℃, 70 ℃ and pH5.0, respectively, the highest enzyme activity was taken as 100%, the relative enzyme activity was calculated, and a temperature-relative enzyme activity curve was constructed. As shown in figure 2, the optimum reaction temperature of the prolease F1 is 45 ℃, the optimum reaction temperature of the prolease mutant F2 is 55 ℃, the enzyme activity of more than 80 percent can be maintained within the range of 45-60 ℃, and the temperature resistance is obviously improved.
2. pH determination of optimum reaction
The recombinant strains Aspergillus niger Su-F1 and Aspergillus niger Su-F2 fermentation crude enzyme liquid obtained in example 3 are diluted and determined by adopting buffer solutions with pH values of 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5 and 7.0 respectively, prolin activity determination is carried out at 37 ℃, enzyme activity is calculated, relative enzyme activity is calculated by taking the highest enzyme activity as 100%, and a pH-relative enzyme activity curve is made. As shown in FIG. 3, the optimum reaction pH of prolease F1 was 4.0, while the optimum reaction pH of prolease mutant F2 was also 4.0, and was not significantly changed.
Example 5 use of Prolinase in beer production
The application one is as follows: adding prolease protease in wort preparation process
1. Preparing 10 identical saccharifying cups, which are respectively named as No. 1-No. 10; adding 250ml of water with the temperature of 55 ℃ and 70g of crushed malt flour into each saccharification cup, and uniformly mixing and dissolving;
2. no. 1 saccharifying cup is used as a blank group, and no other substances are added;
no. 2-4 saccharification cups as experimental group 1, the wild-type prolinases provided by the present invention were added at a ratio of 10u/l, 20u/l, and 30u/l, respectively;
no. 5-7 saccharifying cups are an experimental group 2, and the proline protease mutant provided by the invention is added according to the proportion of 10u/l, 20u/l and 30u/l respectively;
no. 8-10 sugar cups were set as experiment group 3, and no other substances were added for the time being.
3. And (3) saccharification process: preserving heat of No. 1-10 saccharifying cup at 55 deg.C for 30 min, heating to 65 deg.C at a heating rate of 1 deg.C/min, preserving heat for 55 min, heating to 72 deg.C at a heating rate of 1 deg.C/min, preserving heat for 10min, preserving heat at 77 deg.C for 2 min, and rapidly cooling to room temperature. Water was added to each mash cup to 450g, and the resulting mixture was filtered to obtain wort.
4. The initial turbidity of wort nos. 1-7 was measured, and the results are shown in table 1.
5. PPVP (crosslinked polyvinylpyrrolidone, a compound commonly used in breweries at present for reducing the turbidity of beer) was added to wort 8-10 at a ratio of 0.3g/l, 0.6g/l, and 0.9g/l, respectively, and after 30 minutes, the wort was filtered and the initial turbidity was measured, and the specific results are shown in Table 1.
6. Wort turbidity test:
(1) the principle is as follows:
beer tends to develop haze during cryopreservation, mainly because sensitive proteins (proline-rich proteins) in beer tend to bind to polyphenols and cause flocculation. According to the principle of a tannometer, tannin (belonging to polyphenols) is added to accelerate the turbidity of beer, and then the change trend of the turbidity is measured by a turbidimeter, so that the reduction amount of proline protease or PVPP to the turbidity of the beer is determined.
(2) The method comprises the following specific steps:
adding tannin with concentration of 0.1g/l into No. 1-10 wort respectively to make tannin content in wort reach 7.5mg/l, mixing thoroughly for 5min, pouring into glass bottle, measuring turbidity after wort turbidity test with corrected turbidimeter, calculating turbidity reduction amount of wort, and the specific results are shown in Table 1.
Calculating the formula:
the decrease in turbidity (%) > 1- (turbidity after turbidity test in experimental group-initial turbidity in experimental group)/(turbidity after turbidity test in blank group-initial turbidity in blank group) × 100%
TABLE 1 turbidity meter for wheat juice
From the results in table 1, it can be seen that compared with the blank group, the experimental group can significantly reduce the turbidity of the wort after the turbidity test by adding the prolinase provided by the present invention during the wort saccharification process and adding PVPP after the wort saccharification is finished, which indicates that the prolinase and the PVPP can effectively reduce the content of sensitive proteins in the wort, and further reduce the turbidity during the test process. The wort prepared by the experimental groups 1 and 2 added with prolease has a turbidity reduction amount higher than that of the experimental group 3 added with PVPP with a corresponding dosage, so that the effect of the prolease provided by the invention on reducing wort turbidity is obviously better than that of PVPP commonly used in a brewery, turbidity caused by sensitive protein can be effectively reduced, and stability is improved.
Furthermore, the reduction of the wort turbidity of the experimental group 2 added with the prolease mutant is increased by 29.4-48.3% compared with the experimental group 1 added with the wild type prolease with the same dosage, thereby showing that the prolease mutant provided by the invention can better resist high temperature in the wort saccharification process, has obviously better enzymolysis effect on sensitive protein than the wild type prolease, is more beneficial to reducing turbidity caused by the sensitive protein and obtains unexpected effect.
The application II comprises the following steps: proline protease is added in the beer fermentation process
1. The wort is prepared by saccharifying pure malt, filtering, boiling (adding hops), and rotary precipitating.
2. Firstly, respectively adding prolinase and yeast solution provided by the invention into a fermentation tank according to the addition amounts in the table 2, and simultaneously taking the fermentation tank without adding prolinase as a blank control group; then the wort is cooled and oxygenated by a heat exchange pump and then is filled into a fermentation tank; fermenting for 5 days at 9-10 ℃, then heating to 12 ℃, reducing the sugar degree to 3.8-4.20 Bix, sealing the tank, fermenting for 5 days, then cooling to 0 ℃, and finishing the fermentation to obtain the beer solution. After the beer was filtered, the turbidity was measured and the amount of turbidity reduction was calculated, and the results are shown in Table 2.
3. PPVP was added to the beer prepared in the blank control group at a ratio of 0.3g/l, 0.6g/l, and 0.9g/l, respectively, and after 30 minutes, the beer was filtered, and the turbidity was measured to calculate the amount of decrease in turbidity, and the concrete results are shown in Table 2.
Calculating the formula:
turbidity reduction (%) - (blank beer turbidity-experimental beer turbidity)/blank beer turbidity 100%
TABLE 2 beer turbidity Meter
From the data in table 2, it can be seen that compared with the blank control group, the experimental group can significantly reduce the turbidity of beer by adding the prolinase provided by the present invention during the fermentation process and adding PVPP after the fermentation is finished, thereby demonstrating that the prolinase and PVPP can effectively reduce the content of sensitive proteins in beer, and further reduce the generation of turbidity. The decrease of the turbidity of the beer prepared by the experimental groups 1 and 2 added with prolease is obviously higher than that of the experimental group 3 added with corresponding dose of PVPP, so that the effect of the prolease provided by the invention on reducing the beer turbidity is obviously better than that of the PVPP commonly used in breweries at present, the turbidity caused by sensitive protein can be effectively reduced, and the stability of the beer is improved.
Furthermore, the reduction of the turbidity of the beer added in the experimental group 2 of the prolease mutant is improved by 8.9-15.4% compared with that of the experimental group 1 of the wild-type prolease added with the same amount, so that the enzymatic hydrolysis effect of the prolease mutant provided by the invention on sensitive protein in the fermentation process is obviously better than that of the wild-type prolease, the turbidity caused by the sensitive protein is reduced, and an unexpected effect is obtained.
SEQUENCE LISTING
<110> Islands blue biological group Co Ltd
Weifang kang Di En Biotech Co Ltd
<120> prolin mutant and application thereof
<130>
<160>4
<170>PatentIn version 3.5
<210>1
<211>526
<212>PRT
<213>1
<400>1
Met Arg Ser Phe Ser Ala Val Ala Ala Ala Ala Leu Ala Leu Ser Trp
1 5 10 15
Ala Ser Leu Ala Gln Ala Ala Arg Pro Arg Leu Val Pro Lys Pro Val
20 25 30
Pro Arg ProAla Ser Ser Lys Ser Ala Ala Thr Thr Gly Glu Ala Asn
35 40 45
Phe Glu Gln Leu Leu Asp His His Asn Pro Asp Lys Gly Thr Phe Ser
50 55 60
Gln Arg Tyr Trp Trp Ser Thr Glu Tyr Trp Gly Gly Pro Gly Ser Pro
65 70 75 80
Val Val Leu Phe Thr Pro Gly Glu Val Ser Ala Asp Gly Tyr Glu Gly
85 90 95
Tyr Leu Thr Asn Gly Thr Leu Thr Gly Val Tyr Ala Gln Glu Ile Gln
100 105 110
Gly Ala Val Ile Ile Ile Glu His Arg Tyr Trp Gly Asp Ser Ser Pro
115 120 125
Tyr Glu Val Leu Asn Ala Glu Thr Leu Gln Tyr Leu Thr Leu Asp Gln
130 135 140
Ala Val Leu Asp Leu Thr Tyr Phe Ala Glu Thr Val Lys Leu Gln Phe
145 150 155 160
Asp Asn Ser Thr Arg Ser Asn Ala Gln Asn Ala Pro Trp Val Met Val
165 170 175
Gly Gly Ser Tyr Ser Gly Ala Leu Thr Ala Trp Thr Glu Ser Val Ala
180 185 190
Pro Gly Thr Phe Trp AlaTyr His Ala Thr Ser Ala Pro Val Glu Ala
195 200 205
Ile Tyr Asp Phe Trp Gln Tyr Phe Tyr Pro Ile Gln Gln Gly Met Ala
210 215 220
Gln Asn Cys Ser Lys Asp Val Ser Leu Val Ala Glu Tyr Val Asp Lys
225 230 235 240
Val Gly Lys Asn Gly Thr Ala Lys Glu Gln Gln Ala Leu Lys Glu Leu
245 250 255
Phe Gly Leu Gly Ala Val Glu His Phe Asp Asp Phe Ala Ala Val Leu
260 265 270
Pro Asn Gly Pro Tyr Leu Trp Gln Asp Asn Asp Phe Ala Thr Gly Tyr
275 280 285
Ser Ser Phe Phe Gln Phe Cys Asp Ala Val Glu Gly Val Glu Ala Gly
290 295 300
Ala Ala Val Thr Pro Gly Pro Glu Gly Val Gly Leu Glu Lys Ala Leu
305 310 315 320
Ala Asn Tyr Ala Asn Trp Phe Asn Ser Thr Ile Leu Pro Asp Tyr Cys
325 330 335
Ala Gly Tyr Gly Tyr Trp Thr Asp Glu Trp Ser Val Ala Cys Phe Asp
340 345 350
Ser Tyr Asn Ala Ser Ser Pro IleTyr Thr Asp Thr Ser Val Gly Asn
355 360 365
Pro Val Asp Arg Gln Trp Glu Trp Phe Leu Cys Asn Glu Pro Phe Phe
370 375 380
Tyr Trp Gln Asp Gly Ala Pro Glu Gly Thr Ser Thr Ile Val Pro Arg
385 390 395 400
Leu Val Ser Ala Ser Tyr Trp Gln Arg Gln Cys Ser Leu Tyr Phe Pro
405 410 415
Glu Thr Asn Gly Tyr Thr Tyr Gly Ser Ala Lys Gly Lys Asn Ser Ala
420 425 430
Thr Val Asn Ser Trp Thr Gly Gly Arg Asp Met Thr Arg Asn Thr Thr
435 440 445
Arg Leu Ile Trp Thr Asn Gly Gln Tyr Asp Pro Trp Arg Asp Ser Gly
450 455 460
Val Ser Ser Thr Phe Arg Pro Gly Gly Pro Leu Ala Ser Thr Ala Asn
465 470 475 480
Glu Pro Val Gln Val Ile Pro Gly Gly Phe His Cys Ser Asp Leu Tyr
485 490 495
Met Ala Asp Tyr Tyr Ala Asn Glu Gly Val Lys Lys Val Val Asp Asn
500 505 510
Glu Val Lys Gln Ile Lys Glu Trp Val GluGlu Tyr Tyr Ala
515 520 525
<210>2
<211>1581
<212>DNA
<213>2
<400>2
atgcgttcct tctccgctgt cgctgccgca gccctggcgc tctcttgggc gtctctggct 60
caggctgctc gccctcgtct tgtgcccaag cctgtccctc ggccagcttc gagtaaatcg 120
gctgcgacca caggcgaggc taactttgag cagttgctgg accatcataa tccagacaag 180
ggaacgtttt cccagcggta ctggtggagt actgaatact ggggtggtcc tgggtcaccg 240
gttgtcctct ttactcctgg agaggtctct gccgatggct atgaggggta tctcaccaat 300
gggactctca ctggtgttta tgcgcaggag atccagggtg ccgtcattat cattgagcac 360
cgctactggg gtgattcttc gccttatgag gtactcaatg ccgaaactct tcagtatctt 420
acattggacc aagccgttct ggacctgacc tacttcgccg agacggtgaa actgcaattc 480
gataacagca cccgcagcaa tgcgcagaat gctccctggg tcatggtcgg tggatcatac 540
agcggtgcct tgacggcttg gaccgagtct gtcgcgcctg gaacgttctg ggcttaccat 600
gccactagtg ctcctgtgga ggctatctat gacttttggc aatacttcta ccccatccag 660
caaggtatgg cacagaactg cagcaaggac gtgtctctgg tagccgagta tgtcgacaag 720
gttggaaaga acggaactgc caaggagcag caggcactca aggaattgtt tggcttggga 780
gctgttgagc atttcgatga ctttgccgct gtcctcccca acggaccgta cctctggcag 840
gacaacgact ttgccacagg atactcttcc ttcttccagttctgtgacgc cgtcgagggt 900
gtcgaagccg gcgcggcagt aacccccggc cccgagggtg tcggcctcga aaaggccctg 960
gccaactacg caaactggtt caattcaacc attctccctg attactgcgc aggctacggc 1020
tactggaccg acgaatggag cgtcgcctgc ttcgacagct acaacgcctc gagccctatc 1080
tacaccgata catccgtcgg caatcccgtc gaccgccaat gggaatggtt cctttgcaac 1140
gagcctttct tctactggca agacggtgct cccgagggta cctccaccat tgtgccccgg 1200
ctcgtcagcg cctcctactg gcaacgccaa tgctcgctct acttccccga aacgaacggc 1260
tacacgtacg gtagcgcgaa gggtaagaac tctgccacgg tgaacagctg gaccggtggg 1320
cgggacatga cccgcaacac gacgcggttg atctggacga atgggcaata cgacccctgg 1380
cgcgactccg gtgtgtcgag cactttccgg cctggtggac cgctggcgag cacggcgaat 1440
gaacccgtgc aggttattcc gggcggattc cattgctccg atttgtatat ggcagattat 1500
tatgcgaacg agggggtaaa aaaggtggta gataatgagg tgaagcagat taaggagtgg 1560
gtggaggagt attatgcttg a 1581
<210>3
<211>526
<212>PRT
<213>3
<400>3
Met Arg Ser Phe Ser Ala Val Ala Ala Ala Ala Leu Ala Leu Ser Trp
1 5 10 15
Ala Ser Leu Ala Gln Ala Ala Arg Pro Arg Leu Val Pro Lys Pro Val
20 25 30
Pro Arg Pro Ala Ser Ser Lys Ser Ala Ala Thr Thr Gly Glu Ala Asn
35 40 45
Phe Glu Gln Leu Leu Asp His His Asn Pro Asp Lys Gly Thr Phe Ser
50 55 60
Gln Arg Tyr Trp Trp Ser Thr Glu Tyr Trp Gly Gly Pro Gly Ser Pro
65 70 75 80
Val Val Leu Phe Thr Pro Gly Glu Val Ser Ala Asp Gly Tyr Glu Gly
85 90 95
Tyr Leu Thr Asn Glu Thr Leu Thr Gly Val Tyr Ala Gln Glu Ile Gln
100 105 110
Gly Ala Val Ile Ile Ile Glu His Arg Tyr Trp Gly Asp Ser Ser Pro
115 120 125
Tyr Glu Val Leu Asn Ala Glu Thr Leu Gln Tyr Leu Thr Leu Asp Gln
130 135 140
Ala Ile Leu Asp Leu Thr Tyr Phe Ala Glu Thr Val Lys Leu Gln Phe
145 150 155 160
Asp Asn Ser Thr Arg Ser Asn Ala Gln Asn Ala Pro Trp Val Met Val
165 170 175
Gly Gly Ser Tyr Ser Gly Ala Leu Thr Ala Trp Thr Glu Ser Val Ala
180 185 190
Pro Gly Thr Phe Trp Ala Tyr His Ala Thr Ser Ala Pro Val Glu Ala
195 200 205
Ile Tyr Asp Phe Trp Gln Tyr Phe Tyr Pro Ile Gln Gln Gly Met Ala
210 215 220
Gln Asn Cys Ser Lys Asp Val Ser Leu Val Ala Glu Tyr Val Asp Lys
225 230 235 240
Val Gly Lys Asn Gly Thr Ala Lys Glu Gln Gln Ala Leu Lys Glu Leu
245 250 255
Phe Gly Leu Gly Ala Val Glu His Phe Asp Asp Phe Ala Ala Val Leu
260 265 270
Pro Asn Gly Pro Tyr Leu Trp Gln Asp Asn Asp Phe Ala Thr Gly Tyr
275 280 285
Ser Ser Phe Phe Gln Phe Cys Asp Ala Val Glu Gly Val Glu Ala Gly
290 295 300
Ala Ala Val Thr Pro Gly Pro Glu Gly Val Gly Leu Glu Lys Ala Leu
305 310 315 320
Ala Asn Tyr Ala Asn Trp Phe Asn Ser Thr Ile Leu Pro Asp Tyr Cys
325 330 335
Ala Gly Tyr Gly Tyr Trp Thr Asp Glu Trp Ser Val Ala Cys Phe Asp
340 345 350
Ser Tyr Asn Ala Ser Ser Pro Ile Tyr Thr Asp Thr Ser Val Gly Asn
355 360 365
Pro Val Asp Arg Gln Trp Glu Trp Phe Leu Cys Asn Glu Pro Phe Phe
370 375 380
Tyr Trp Gln Asp Gly Ala Pro Glu Gly Thr Ser Thr Ile Val Pro Arg
385 390 395 400
Leu Val Ser Ala Ser Tyr Trp Gln Arg Gln Cys Ser Leu Tyr Phe Pro
405 410 415
Glu Thr Asn Gly Tyr Thr Tyr Gly Ser Ala Lys Gly Lys Asn Ser Ala
420 425 430
Thr Val Asn Ser Trp Thr Gly Gly Trp Asp Met Thr Arg Asn Thr Thr
435 440 445
Arg Leu Ile Trp Thr Asn Gly Gln Tyr Asp Pro Trp Arg Asp Ser Gly
450 455 460
Val Ser Ser Thr Phe Arg Pro Gly Gly Pro Leu Ala Ser Thr Ala Asn
465 470 475 480
Glu Pro Val Gln Val Ile Pro Gly Gly Phe His Cys Ser Asp Leu Tyr
485 490 495
Met Ala Asp Tyr Tyr Ala Asn Glu Gly Val Lys Lys Val Val Asp Asn
500 505 510
Glu Val Lys Gln Ile Lys Glu Trp Val Glu Glu Tyr Tyr Ala
515 520 525
<210>4
<211>1581
<212>DNA
<213>4
<400>4
atgcgttcct tctccgctgt cgctgccgca gccctggcgc tctcttgggc gtctctggct 60
caggctgctc gccctcgtct tgtgcccaag cctgtccctc ggccagcttc gagtaaatcg 120
gctgcgacca caggcgaggc taactttgag cagttgctgg accatcataa tccagacaag 180
ggaacgtttt cccagcggta ctggtggagt actgaatact ggggtggtcc tgggtcaccg 240
gttgtcctct ttactcctgg agaggtctct gccgatggct atgaggggta tctcaccaat 300
gagactctca ctggtgttta tgcgcaggag atccagggtg ccgtcattat cattgagcac 360
cgctactggg gtgattcttc gccttatgag gtactcaatg ccgaaactct tcagtatctt 420
acattggacc aagccattct ggacctgacc tacttcgccg agacggtgaa actgcaattc 480
gataacagca cccgcagcaa tgcgcagaat gctccctggg tcatggtcgg tggatcatac 540
agcggtgcct tgacggcttg gaccgagtct gtcgcgcctg gaacgttctg ggcttaccat 600
gccactagtg ctcctgtgga ggctatctat gacttttggc aatacttcta ccccatccag 660
caaggtatgg cacagaactg cagcaaggac gtgtctctgg tagccgagta tgtcgacaag 720
gttggaaaga acggaactgc caaggagcag caggcactca aggaattgtt tggcttggga 780
gctgttgagc atttcgatga ctttgccgct gtcctcccca acggaccgta cctctggcag 840
gacaacgact ttgccacagg atactcttcc ttcttccagt tctgtgacgc cgtcgagggt 900
gtcgaagccg gcgcggcagt aacccccggc cccgagggtg tcggcctcga aaaggccctg 960
gccaactacg caaactggtt caattcaacc attctccctg attactgcgc aggctacggc 1020
tactggaccg acgaatggag cgtcgcctgc ttcgacagct acaacgcctc gagccctatc 1080
tacaccgata catccgtcgg caatcccgtc gaccgccaat gggaatggtt cctttgcaac 1140
gagcctttct tctactggca agacggtgct cccgagggta cctccaccat tgtgccccgg 1200
ctcgtcagcg cctcctactg gcaacgccaa tgctcgctct acttccccga aacgaacggc 1260
tacacgtacg gtagcgcgaa gggtaagaac tctgccacgg tgaacagctg gaccggtggg 1320
tgggacatga cccgcaacac gacgcggttg atctggacga atgggcaata cgacccctgg 1380
cgcgactccg gtgtgtcgag cactttccgg cctggtggac cgctggcgag cacggcgaat 1440
gaacccgtgc aggttattcc gggcggattc cattgctccg atttgtatat ggcagattat 1500
tatgcgaacg agggggtaaa aaaggtggta gataatgagg tgaagcagat taaggagtgg 1560
gtggaggagt attatgcttg a 1581
Claims (6)
1. A proline protease mutant characterized in that the 101 th amino acid of prolinase having the amino acid sequence of SEQ ID NO. 1 is changed from Gly to Glu, the 146 th amino acid is changed from Val to Ile, and the 441 th amino acid is changed from Arg to Trp.
2. The mutant of claim 1, wherein the amino acid sequence of said mutant is SEQ ID No. 3.
3. The mutant encoding gene of claim 1, wherein one nucleotide sequence of the encoding gene is SEQ ID NO: 4.
4. a recombinant plasmid carrying the coding gene of claim 3.
5. A recombinant strain carrying the recombinant plasmid of claim 4.
6. Use of the prolease mutant according to claim 1 or 2 for reducing haze in beer or beverage.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611130005.1A CN106754837B (en) | 2016-12-09 | 2016-12-09 | Proline protease mutant and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611130005.1A CN106754837B (en) | 2016-12-09 | 2016-12-09 | Proline protease mutant and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106754837A CN106754837A (en) | 2017-05-31 |
CN106754837B true CN106754837B (en) | 2020-04-14 |
Family
ID=58875084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611130005.1A Active CN106754837B (en) | 2016-12-09 | 2016-12-09 | Proline protease mutant and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106754837B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7309595B2 (en) * | 2000-12-07 | 2007-12-18 | Dsm Ip Assets B.V. | Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
CN102071173A (en) * | 2010-12-03 | 2011-05-25 | 张明 | Multi-enzyme preparation capable of effectively reducing malt and beer turbidity |
-
2016
- 2016-12-09 CN CN201611130005.1A patent/CN106754837B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7309595B2 (en) * | 2000-12-07 | 2007-12-18 | Dsm Ip Assets B.V. | Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
CN102071173A (en) * | 2010-12-03 | 2011-05-25 | 张明 | Multi-enzyme preparation capable of effectively reducing malt and beer turbidity |
Non-Patent Citations (1)
Title |
---|
黑曲霉来源脯氨酰蛋白酶在无孢黑曲霉SH-2 中表达的研究;何攀;《中国优秀硕士学位论文基础科学辑》;20150115;第A006-206页 * |
Also Published As
Publication number | Publication date |
---|---|
CN106754837A (en) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112646792A (en) | Low-temperature inulase exonuclease mutant MutA122 delta 5 with reduced thermal stability and application | |
CN107012130A (en) | A kind of glucose oxidase mutant and its encoding gene and application | |
EP4026903A1 (en) | Allulose 3-epimerase mutant, engineered bacterium expressing same, and immobilized enzyme and immobilization method thereof | |
CN111893125A (en) | Chitosan enzyme gene, chitosanase, preparation method and application thereof | |
CN112725309A (en) | Low-temperature inulase exo-mutant MutP126R stable at medium temperature | |
CN107400666B (en) | A kind of aminopeptidase and its coding gene and application | |
CN109486800B (en) | Novel lysyl endopeptidase and preparation method thereof | |
CN108118037A (en) | The glucose oxidase mutant that a kind of heat resistance improves | |
CN108251391A (en) | Novel grape carbohydrate oxidase mutant | |
CN108251389A (en) | The glucose oxidase mutant that a kind of heat resistance improves | |
CN113549609A (en) | Carbonic anhydrase SaCA and coding gene and application thereof | |
CN101348795A (en) | A kind of coding gene of glucose oxidase and its preparation method and application | |
CN108118036A (en) | Novel grape carbohydrate oxidase mutant | |
CN106754837B (en) | Proline protease mutant and application thereof | |
CN107164346B (en) | An alkaline salt-tolerant pullulanase PulA and its gene and application | |
CN109943548A (en) | A kind of method for improving the yield of synthetic L-arginine by Corynebacterium blunter | |
CN113308453A (en) | Amidohydrolase SaAH, and coding gene and application thereof | |
CN109161556B (en) | M1PDH gene in kelp, protein and application thereof | |
CN118207187A (en) | High specific activity amylase mutant | |
CN110106160B (en) | Alkaline protease mutant PROK-G with improved catalytic activity and its encoding gene and application | |
CN109423483B (en) | Glucose oxidase mutant | |
CN109161489B (en) | Aspergillus niger strain with high yield of acid protease | |
CN103589741A (en) | Novel proline specific endoprotease gene and application thereof | |
CN106635845B (en) | Aspergillus niger strain capable of producing prolin protease at high yield | |
CN113755474A (en) | A kind of carboxypeptidase and its encoding gene and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |